ADMA

ADMA Biologics, Inc.

Healthcare · USD

Set alert

Price alert · ADMA

All alert types
11.41 USD -0.34 -2.89%
As of Oct 30, 2026 Extended hours 11.25 -1.40%
Bid
11.42 × 2
Ask
11.43 × 2
11.37 Day range 11.90
7.21 52-week range 20.46
YTD
-37.45%
1 year
-25.28%
Open
11.85
Prev close
11.75
Mkt cap
2.56B
Vol
2.46M
Avg vol
2.68M
EPS
0.70
P/E
16.30
Div yield
0.00%
More statistics
Low
11.37
High
11.90
Forward P/E
12.07
Beta
0.69
Short ratio
5.82
Inst. own
92.51%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
9.97
200-d avg
10.99
1y target
17.00

5D chart

Chart tools
Interval
ADMA five-day price chart10.711.011.311.611.9Oct 26Oct 27Oct 28Oct 29Oct 30Oct 30

Period ending Jun 30, 2026 · select a line to chart its history

Revenue & Expenses

Revenue by
United States → Revenue: $123.32MRevenue → Gross Profit: $86.28MGross Profit → Net Income: $37.82MGross Profit → Selling, General & Admin: $26.74MGross Profit → Research & Development: $6.01MRevenue → Cost of Revenue: $38.12MGross Profit → Other Operating Expenses: $1.08MGross Profit → Other Expenses: $2.21MGross Profit → Income Tax: $12.41MNon-US → Revenue: $1.08MGross Profit$86.28MCost of Revenue$38.12MNet Income$37.82MSelling, General & Admin$26.74MResearch & Development$6.01MOther Operating Expenses$1.08MOther Expenses$2.21MIncome Tax$12.41MRevenue$124.39MUnited States$123.32MNon-US$1.08M

Income statement

ADMA quarterly income statement
124.39M
124.39M
38.12M
86.28M
33.83M
6.01M
26.74M
52.45M
3.42M
12.41M
37.82M
37.82M
37.82M
37.82M
0.17
0.17
0.16
53.66M
53.66M
228.23M
230.34M

Balance sheet

ADMA quarterly balance sheet
136.02M
136.02M
138.23M
528.20M
72.81M
684.21M
4.93M
197.77M
75.76M
192.84M
276.00M
-78.50M
408.21M
408.21M
156.01M
197.77M
1.33M
4.11M
239.31M
200.25M
31.72M
69.97M

Cash flow

ADMA quarterly cash flow
1.78M
-29.42M
-2.13M
-2.26M
-25.02M
-469.00K
-2.26M
29.54M
6.13M